Cancer Investigation : Impact Factor & More

eISSN: 1532-4192pISSN: 0735-7907

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Aims and Scope

Cancer Investigation is a peer-reviewed medical journal in the field of basic and clinical oncology. The editor in chief is Gary Lyman. It is currently indexed for MEDLINE.

Cancer Investigation Key Metrics

CiteScore
3.2
H-Index
90
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.61
Time to Accept
7
 Mo
Time to Publish
time-to-publish View Chart
7
 Mo
Time to Publish

Sign up now and unlock a detailed chart of Time to publish for this journal

% of papers by time taken from submission to publication
0 to 3 months
8%
4 to 6 months
36%
7 to 9 months
15%
Above 9 months
41%

Topics Covered on Cancer Investigation

Cancer
Lung cancer
Sinonasal undifferentiated carcinoma
Overall survival
Fibrinogen
Hepatocellular carcinoma
Tumor microenvironment
Prostate cancer
Breast cancer
Magnetic resonance imaging
Radiation
Transarterial Radioembolization
Colorectal cancer
Prostatectomy
Type 2 diabetes
Self-efficacy
Mitochondrial DNA
Cancer immunotherapy
Clinical trial
Absolute lymphocyte count

Cancer Investigation Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1983
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cancer Investigation ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Investigation

Compare Similar Journals with Cancer Investigation

Select Journals to Compare with Cancer Investigation
Total journals - 10
You can select up to 3 Journals at a time

Journal of Clinical Oncology

Publisher: LIPPINCOTT WILLIAMS & WILKINS

Frontiers in Oncology

Publisher: FRONTIERS MEDIA SA

Cancers

Publisher: MDPI

Annals of Oncology

Publisher: ELSEVIER

Cancer Research

Publisher: AMER ASSOC CANCER RESEARCH

PLoS ONE

Publisher: PUBLIC LIBRARY SCIENCE

Scientific Reports

Publisher: NATURE PORTFOLIO

BMC Cancer

Publisher: BMC

Medicine

Publisher: Elsevier

Oncotarget

Publisher: Impact Journals
0 Journals Selected to compare with
Cancer Investigation
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers

Get detailed Journal comparison report on your email by signing up

Check if your research matches the topics covered in Cancer Investigation?

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your research

FAQs on Cancer Investigation

How long has Cancer Investigation been actively publishing? expand

Cancer Investigation has been in operation since 1983 till date.

What is the publishing frequency of Cancer Investigation? expand

Cancer Investigation published with a Monthly frequency.

How many articles did Cancer Investigation publish last year? expand

In 2023, Cancer Investigation publsihed 67 articles.

What is the eISSN & pISSN for Cancer Investigation? expand

For Cancer Investigation, eISSN is 1532-4192 and pISSN is 0735-7907.

What is Citescore for Cancer Investigation? expand

Citescore for Cancer Investigation is 3.2.

What is the H Index for Cancer Investigation ? expand

H Index for Cancer Investigation is 90.

What is SNIP score for Cancer Investigation? expand

SNIP score for Cancer Investigation is 0.61.

What is the SJR for Cancer Investigation? expand

SJR for Cancer Investigation is Q2.

Who is the publisher of Cancer Investigation? expand

TAYLOR & FRANCIS INC is the publisher of Cancer Investigation.